CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

ARDXARDELYX, INC.

NASDAQ · Pharmaceutical Preparations
Last close $3.42 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$852.22M
RECENT INSIDER TRADES
  • 2026-08-25 · Bishop John E (See Remarks) · SELL
  • 2026-08-25 · RAAB MICHAEL (President & CEO) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders268
Shares held228,813,184
Value$1.23B
Percent of shares outstanding91.82%
As of quarter end2026-06-30
RECENT NEWS
  • ARDX: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
  • ARDX: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
  • ARDX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Ardelyx Investors of Securities Class Action Lawsuit Deadline on November 16, 2026
  • ARDX: ROSEN, A LEADING NATIONAL FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
  • ARDX: Kaplan Fox Announces a Securities Class Action Filed Against Ardelyx, Inc. (ARDX) - Lead Plaintiff Deadline is November 16, 2026
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS